Figure 6.
AEs in the treated population (N = 46) at any time and during KRd induction/consolidation or lenalidomide maintenance.

AEs in the treated population (N = 46) at any time and during KRd induction/consolidation or lenalidomide maintenance.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal